ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

TEM Tempus AI Inc

41.55
1.41 (3.51%)
20 Jul 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Tempus AI Inc NASDAQ:TEM NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  1.41 3.51% 41.55 20.00 45.50 42.8451 39.90 41.00 442,787 05:00:02

Tempus to Report Second Quarter 2024 Financial Results on August 6

17/07/2024 2:30pm

Business Wire


Tempus AI (NASDAQ:TEM)
Historical Stock Chart


From Jun 2024 to Jul 2024

Click Here for more Tempus AI Charts.

Tempus AI, Inc. (NASDAQ: TEM), a leader in artificial intelligence and precision medicine, today announced they will report financial results for the second quarter on Tuesday, August 6, 2024. The company will hold the second quarter 2024 earnings conference call at 4:30 p.m. ET. The company’s quarterly earnings will be released the same day.

The call will feature Tempus Founder and CEO, Eric Lefkofsky, and Chief Financial Officer, Jim Rogers. The live audio webcast will be accessible through the events page of Tempus’ Investor Relations website. Alternatively, the call can be accessed via the following:

Conference ID: 6326328 Domestic Dial-in Number: (800) 715-9871 International Dial-in Number: (646) 307-1963 Live Webcast: https://edge.media-server.com/mmc/p/75k462fh

About Tempus

Tempus is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. With one of the world’s largest libraries of multimodal data, and an operating system to make that data accessible and useful, Tempus provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. The goal is for each patient to benefit from the treatment of others who came before by providing physicians with tools that learn as the company gathers more data. For more information, visit tempus.com.

Tempus Communications Erin Carron Erin.carron@tempus.com

Tempus Investor Relations Elizabeth Krutoholow Elizabeth.krutoholow@tempus.com

H/Advisors Abernathy Dan Scorpio Dan.scorpio@h-advisors.global

1 Year Tempus AI Chart

1 Year Tempus AI Chart

1 Month Tempus AI Chart

1 Month Tempus AI Chart